288330 — Parataxis Korea Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Bridge Biotherapeutics Announces Completion Of Enrollment In The Phase 2A Clinical Study Of BBT-877 For The Treatment Of Idiopathic Pulmonary Fibrosis
Brief: Bridge Biotherapeutics Launches A Research Collaboration With Emory University School Of Medicine
Brief: Bridge Biotherapeutics Announces A Research Collaboration With The University Of Colorado School Of Medicine
Brief: Bridge Biotherapeutics To Conduct Capital Increase Of 2 Billion Won For Operational Funds
Brief: Bridge Biotherapeutics Announces First Patient Dosed In Its Phase 2A Clinical Trial Of BBT-877
Brief: Bridge Biotherapeutics Presents Phase 2A Clinical Trial Results For Bbt-401, A Drug Candidate To Treat Ulcerative Colitis
Brief: Bridge Biotherapeutics, Scripps Research Launch Research Collaboration